Jeffrey Cole

Jeffrey Cole

Chief Operating Officer at CADRENAL THERAPEUTICS, INC.

Net worth: - $ as of 29/04/2024

56 year
Consumer Services
Finance
Distribution Services

Profile

Jeffrey S.
Cole
is the founder of Espero Pharmaceuticals, Inc. He is currently the Chief Operating Officer at Cadrenal Therapeutics, Inc. since 2024.
Previously, he served as the Chief Financial Officer at Legacy Pharmaceuticals International GmbH from 2008 to 2010.
Mr. Cole completed his undergraduate degree at the University of Southern California and holds an MBA from the University of Michigan.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/04/2024 0 ( -.--% ) - $ 29/04/2024

Jeffrey Cole active positions

CompaniesPositionStart
CADRENAL THERAPEUTICS, INC. Chief Operating Officer 07/02/2024
All active positions of Jeffrey Cole

Former positions of Jeffrey Cole

CompaniesPositionEnd
Director of Finance/CFO 31/07/2010
Founder -
See the detail of Jeffrey Cole's experience

Training of Jeffrey Cole

University of Southern California Undergraduate Degree
University of Michigan Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jeffrey Cole's experience

Connections

7

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
CADRENAL THERAPEUTICS, INC.

Health Technology

Private companies2

Finance

Distribution Services

See company connections